CSPC PHARMA (01093) Schedules 25 March 2026 Board Meeting for FY2025 Results and Final Dividend Deliberation

Bulletin Express03-13

CSPC Pharmaceutical Group Limited (CSPC PHARMA, stock code: 01093) will convene a Board of Directors meeting on 25 March 2026. According to the announcement released on 13 March 2026, the agenda includes:

• Approval of the consolidated annual results of CSPC PHARMA and its subsidiaries for the financial year ended 31 December 2025.

• Consideration of a final dividend payment, if any, for the same period.

The Board currently comprises 18 directors: 12 executive directors—Cai Dong Chen (Chairman), Cai Lei, Wei Qingjie, Zhang Cuilong, Wang Zhenguo, Wang Huaiyu, Li Chunlei, Yao Bing, Cai Xin, Chen Weiping, Qu Zhiyong and Zhang Yiwei—and six independent non-executive directors—Wang Bo, Chen Chuan, Prof. Wang Hongguang, Au Chun Kwok Alan, Law Cheuk Kin Stephen and Li Quan.

The forthcoming meeting will formalize the FY2025 financial statements and determine the proposed final dividend, setting the stage for shareholder communication and subsequent annual general meeting proceedings.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1126822689?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 21:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126822689","market":"hk","top_or_hot":-1,"title":"CSPC PHARMA (01093) Schedules 25 March 2026 Board Meeting for FY2025 Results and Final Dividend Deliberation","media":"Bulletin Express","content":"<p>CSPC Pharmaceutical Group Limited (CSPC PHARMA, stock code: 01093) will convene a Board of Directors meeting on 25 March 2026. According to the announcement released on 13 March 2026, the agenda includes:</p>\n<p>• Approval of the consolidated annual results of CSPC PHARMA and its subsidiaries for the financial year ended 31 December 2025.</p>\n<p>• Consideration of a final dividend payment, if any, for the same period.</p>\n<p>The Board currently comprises 18 directors: 12 executive directors—Cai Dong Chen (Chairman), Cai Lei, Wei Qingjie, Zhang Cuilong, Wang Zhenguo, Wang Huaiyu, Li Chunlei, Yao Bing, Cai Xin, Chen Weiping, Qu Zhiyong and Zhang Yiwei—and six independent non-executive directors—Wang Bo, Chen Chuan, Prof. Wang Hongguang, Au Chun Kwok Alan, Law Cheuk Kin Stephen and Li Quan.</p>\n<p>The forthcoming meeting will formalize the FY2025 financial statements and determine the proposed final dividend, setting the stage for shareholder communication and subsequent annual general meeting proceedings.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CSPC PHARMA (01093) Schedules 25 March 2026 Board Meeting for FY2025 Results and Final Dividend Deliberation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCSPC PHARMA (01093) Schedules 25 March 2026 Board Meeting for FY2025 Results and Final Dividend Deliberation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-13 21:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CSPC Pharmaceutical Group Limited (CSPC PHARMA, stock code: 01093) will convene a Board of Directors meeting on 25 March 2026. According to the announcement released on 13 March 2026, the agenda includes:</p>\n<p>• Approval of the consolidated annual results of CSPC PHARMA and its subsidiaries for the financial year ended 31 December 2025.</p>\n<p>• Consideration of a final dividend payment, if any, for the same period.</p>\n<p>The Board currently comprises 18 directors: 12 executive directors—Cai Dong Chen (Chairman), Cai Lei, Wei Qingjie, Zhang Cuilong, Wang Zhenguo, Wang Huaiyu, Li Chunlei, Yao Bing, Cai Xin, Chen Weiping, Qu Zhiyong and Zhang Yiwei—and six independent non-executive directors—Wang Bo, Chen Chuan, Prof. Wang Hongguang, Au Chun Kwok Alan, Law Cheuk Kin Stephen and Li Quan.</p>\n<p>The forthcoming meeting will formalize the FY2025 financial statements and determine the proposed final dividend, setting the stage for shareholder communication and subsequent annual general meeting proceedings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01093","symbol_name":"石药集团","start_time":0,"source_url":"","article_id":"1126822689","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126822689","pubTimestamp":1773408178,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CSPC Pharmaceutical Group Limited (CSPC PHARMA, stock code: 01093) will convene a Board of Directors meeting on 25 March 2026. According to the announcement released on 13 March 2026, the agenda...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01093":"石药集团"},"translate_title":"石药集团(01093)定于2026年3月25日召开董事会，审议2025财年业绩及末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01093":1},"content_text":"CSPC Pharmaceutical Group Limited (CSPC PHARMA, stock code: 01093) will convene a Board of Directors meeting on 25 March 2026. According to the announcement released on 13 March 2026, the agenda includes:\n• Approval of the consolidated annual results of CSPC PHARMA and its subsidiaries for the financial year ended 31 December 2025.\n• Consideration of a final dividend payment, if any, for the same period.\nThe Board currently comprises 18 directors: 12 executive directors—Cai Dong Chen (Chairman), Cai Lei, Wei Qingjie, Zhang Cuilong, Wang Zhenguo, Wang Huaiyu, Li Chunlei, Yao Bing, Cai Xin, Chen Weiping, Qu Zhiyong and Zhang Yiwei—and six independent non-executive directors—Wang Bo, Chen Chuan, Prof. Wang Hongguang, Au Chun Kwok Alan, Law Cheuk Kin Stephen and Li Quan.\nThe forthcoming meeting will formalize the FY2025 financial statements and determine the proposed final dividend, setting the stage for shareholder communication and subsequent annual general meeting proceedings.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1126822689","isCrawlerRequest":true}